<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04701567</url>
  </required_header>
  <id_info>
    <org_study_id>BASEC ID 2020-01313</org_study_id>
    <nct_id>NCT04701567</nct_id>
  </id_info>
  <brief_title>Diagnostic and Evaluation of Hepato-pancreatico-biliary Disease With MRI</brief_title>
  <official_title>Diagnostik Und Evaluierung Hepato-pankreatiko-bili√§rer Erkrankungen Mittels Morphologischer Und Funktioneller Magnetresonanztomographie</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a retrospective review of images from patient data. There is no recruitment necessary&#xD;
      for this study.&#xD;
&#xD;
      Research Question: Can advanced multiparametric MRI techniques improve the detection and&#xD;
      characterization of focal and diffuse liver disease, accurately assess treatment response and&#xD;
      predict patient outcomes based on longitudinal monitoring? Hypotheses: Advanced&#xD;
      multiparametric MRI techniques improve the detection, characterization and response&#xD;
      assessment of focal and diffuse liver disease and can predict serious liver related outcomes.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 30, 2020</start_date>
  <completion_date type="Anticipated">December 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Pathology findings in focal and/or diffuse liver disease</measure>
    <time_frame>1 year</time_frame>
    <description>Pathology findings in focal and/or diffuse liver disease</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pathology findings in focal and/or diffuse pancreatic disease</measure>
    <time_frame>1 year</time_frame>
    <description>Pathology findings in focal and/or diffuse pancreatic disease</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Liver Diseases</condition>
  <condition>Pancreas Disease</condition>
  <arm_group>
    <arm_group_label>Liver disease</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Pancreatic disease</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Magnetic resonance imaging</intervention_name>
    <description>Advanced multiparametric MRI techniques to diagnose hepatic and pancreatic disease</description>
    <arm_group_label>Liver disease</arm_group_label>
    <arm_group_label>Pancreatic disease</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with suspicion for or diagnosed focal and/or diffuse liver or pancreatic disease&#xD;
        who underwent MRI of the abdomen.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with suspicion for or diagnosed focal and/or diffuse liver or pancreatic&#xD;
             disease who underwent MRI of the abdomen.&#xD;
&#xD;
          -  18 years of age and older.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age less than 18 years.&#xD;
&#xD;
          -  Lack of MRI of the abdomen.&#xD;
&#xD;
          -  Inadequate image quality.&#xD;
&#xD;
          -  Documented rejection to participate in research studies&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Caecilia Reiner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Zurich</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Caecilia Reiner, MD</last_name>
    <phone>+41442551111</phone>
    <email>caecilia.reiner@usz.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Reiner</last_name>
    <email>caecilia.reiner@usz.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caecilia Reiner, MD</last_name>
      <phone>+41442551111</phone>
    </contact>
    <contact_backup>
      <last_name>Reiner</last_name>
      <email>caecilia.reiner@usz.ch</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 6, 2021</study_first_submitted>
  <study_first_submitted_qc>January 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 8, 2021</study_first_posted>
  <last_update_submitted>January 6, 2021</last_update_submitted>
  <last_update_submitted_qc>January 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Zurich</investigator_affiliation>
    <investigator_full_name>Caecilia Reiner</investigator_full_name>
    <investigator_title>Staff Radiologist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Pancreatic Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

